Clinical Trials

40 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung

NCT00420381 2020-12-19

Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer

28 enrolled 13 charts

Gynecologic

Carcinoma, Neoplasms, Ovarian Neoplasms, Recurrence

NCT00466440 2020-11-06

A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients

108 enrolled 22 charts

Genitourinary

Prostatic Neoplasms

NCT00415363 2020-11-05

Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy

109 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT00391118 2020-10-19

Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")

153 enrolled 20 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT00542919 2020-10-19

A Study for Patients With Non-Hodgkin's Lymphomas

57 enrolled 16 charts

Lymphoma, B-Cell, Lymphoma, T-Cell

NCT00744991 2020-10-19

A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma

25 enrolled 14 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT01432951 2020-10-12

A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma

26 enrolled 10 charts

Lymphoma

NCT00536939 2020-09-24

Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer

Phase 2 Terminated

2 enrolled 5 charts

Breast

Breast Neoplasms

NCT00586508 2020-09-24

Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas

81 enrolled 11 charts

Glioblastoma

NCT00414960 2020-09-21

A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers

40 enrolled 12 charts

Lung Neoplasms

NCT00718419 2020-09-03

A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma

56 enrolled 12 charts

LymphoidPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT00267020 2020-08-31

Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer

130 enrolled 19 charts

Pancreatic Neoplasms

NCT00042666 2020-08-10

A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.

55 enrolled 13 charts

Lymphoma, Non-Hodgkin

NCT00437294 2020-08-10

Enzastaurin in Combination of Capecitabine to Treat Breast Cancer

Phase 2 Terminated

86 enrolled 20 charts

Breast

Breast Neoplasms

NCT00192114 2020-08-06

Enzastaurin for Patients With Metastatic Colorectal Cancer

28 enrolled 18 charts

Colonic Neoplasms

NCT00402116 2020-08-06

Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

Phase 1/2 Completed

72 enrolled 19 charts

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00436280 2020-08-06

Chemotherapy for Participants With Lymphoma

68 enrolled 20 charts

Lymphoma, Large B-Cell, Diffuse

NCT00437268 2020-07-21

A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer

26 enrolled 19 charts

Colorectal Neoplasms

NCT00451178 2020-07-21

A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only

101 enrolled 15 charts

Lymphoma

NCT00612586 2020-07-21

Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer

117 enrolled 15 charts

Colorectal Neoplasms

NCT00088205 2020-07-01

Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma

60 enrolled 17 charts

Lymphoma, Mantle-Cell

NCT00530621 2020-07-01

Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer

160 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT01388335 2020-07-01

A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

13 enrolled 17 charts

Lymphoma

NCT00309140 2020-06-26

An Open Label Study of Oral Enzastaurin in Participants With Cancer

23 enrolled 13 charts

Tumor-Agnostic

Neoplasms

NCT00451555 2019-11-01

Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer

156 enrolled 15 charts

Breast

Breast Neoplasms

NCT00509821 2019-04-05

Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma

60 enrolled 11 charts

Glioblastoma

NCT00475644 2018-11-05

A Study of Enzastaurin in Participants With Follicular Lymphoma

66 enrolled 12 charts

Lymphoma, Follicular

NCT01445119 2013-08-28

A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas

58 enrolled

Brain Neoplasms, Glioma, Neoplasms

NCT00452257 2009-03-19

A Study of Enzastaurin in Patients With Leukemia

Other hematologic neoplasm

18 enrolled

Leukemia, Lymphoid

NCT00105092 2007-05-01

Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00190723 2007-01-26

A Study of LY317615 in Patients With Brain Tumors

120 enrolled